Search results for: pediatric rheumatology

Management of Adults with JIA: Uveitis, MAS & More

Mary Beth Nierengarten | December 2, 2021

Mara L. Becker, MD, MSCE, discusses how important it is to effectively treat juvenile idiopathic arthritis at an early stage to improve long-term outcomes in adulthood.

Experts Discuss Blood Disorders Commonly Seen in Lupus Patients

Samantha C. Shapiro, MD | December 2, 2021

ACR CONVERGENCE 2021—Hematologic abnormalities are common in systemic lupus erythematosus (SLE), whether due to SLE itself or something else. As rheumatology professionals, we are routinely challenged by the management of cytopenias in our SLE patients. At the ACR’s annual meeting in 2021, two hematologists shared expert advice regarding common hematologic manifestations of SLE. Michael B….

Research Helps Explain Idiosyncrasies of COVID-19

Jason Liebowitz, MD, FACR | November 23, 2021

The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.

Policy Change Made Reality in 2021

Thomas R. Collins | November 18, 2021

After a year marked with rheumatology gains in evaluation and management valuation, as well as quality reporting, ongoing ACR efforts target impending Medicare reimbursement cuts and other practice challenges.

Case Report: Rheumatoid Arthritis Complicated by Large Granular Lymphocytic Leukemia

Nam D. Nguyen, DO (Maj., USAF, MC), Erica Hill, DO (Lt. Col., USAF, MC), & Jay Higgs, MD (Col. [ret], USAF, MC) | November 14, 2021

Large granular lymphocytic (LGL) leukemia is a rare, chronic, lymphoproliferative disorder of cytotoxic T cell or natural killer cell lineage with an annual incidence of 0.72 cases per 1 million people in the U.S.1 The most common subtype of LGL leukemia, T-LGL leukemia, follows an indolent disease course and accounts for approximately 85% of cases….

Understanding Risk in the COVID-19 Era

Ethan Craig, MD, MHS | November 14, 2021

On Sept. 9, my 5-year-old son boarded a bus for his first day of kindergarten. In some senses, this was no different from any other year. We spent weeks trying to get him excited for school (he is not a fan of changes). We went to kindergarten orientation, toured his classroom and sat on his…

Barbara Slusher, MSW, PA-C, Takes the Reins of ARP

Leslie Mertz, PhD | November 8, 2021

Ms. Slusher brings a varied background and many goals to her new role as ARP president, including engaging with volunteers and building connections with all members of healthcare teams.

ACR Convergence 2021: Advocacy Successes & Challenges

Thomas R. Collins | October 25, 2021

The ACR’s advocacy efforts over the past year have helped put critical prior authorization and step therapy legislation in front of Congress. Learn more at ACR Convergence 2021.

Regressed germinal center with follicular dendritic cell prominence (star), onion-skinning (blue arrowhead) and increased vascularity (orange arrows) are seen.

Case Report: Is It Castleman Disease, or Castleman-Like?

Philip Chu, MD, RhMSUS, Mithu Maheswaranathan, MD, Jadee L. Neff, MD, PhD, & Rebecca E. Sadun, MD, PhD | October 13, 2021

The difference between Castleman disease and Castleman-like disease may be subtle, but it comes with significant ramifications. Case Presentation This case involves a pregnant 19-year-old woman who presents over multiple hospitalizations with concerns for systemic lupus erythematosus and macrophage activation syndrome. At 36 weeks’ gestation, the patient’s weight had dropped from 215 lbs. to 170…